New Biomarkers (Endocan, Interleukin-17, and Thrombospondin-4) for the Diagnosis, Assessment of Severity, and Follow-Up of Peripheral Arterial Disease.
atherosclerosis
endocan
interleukin-17
peripheral arterial disease
thrombospondin-4
Journal
Angiology
ISSN: 1940-1574
Titre abrégé: Angiology
Pays: United States
ID NLM: 0203706
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
medline:
19
6
2023
pubmed:
4
4
2023
entrez:
3
4
2023
Statut:
ppublish
Résumé
The present study evaluated the use of endocan, interleukin-17 (IL-17), and thrombospondin-4 (TSP-4) blood levels as potential biomarkers for the diagnosis and follow-up of peripheral arterial disease (PAD). Patients with PAD (Rutherford categories I, II, and III) who were admitted between March 2020 and March 2022 for cardiovascular surgery or outpatient clinic follow-up were included. The patients (
Identifiants
pubmed: 37010303
doi: 10.1177/00033197231166492
doi:
Substances chimiques
Interleukin-17
0
Neoplasm Proteins
0
Biomarkers
0
Thrombospondins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM